Tag Archives: Dr. Paul Greengard
gSAP: A Key Protein in Plaque Formation
By: www.ALZinfo.org Dr. Gen He and Dr. Paul Greengard of the Fisher Center for Alzheimer’s Disease Research laboratory have discovered a protein that stimulates the production of beta-amyloid, the toxic protein that is linked to the development of plaques in … Continue reading
Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants
Proceedings of the National Academy of Sciences April 25, 2011 Publication: Click Here Scientists at the Fisher Center for Alzheimer’s Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, … Continue reading
Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants
Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants Scientists at the Fisher Center for Alzheimer’s Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which … Continue reading
SMER28
Journal of Federation of American Societies for Experimental Biology March 7, 2011 Full PDF: Click Here Fisher Scientists Discover New Ways to Rid Cells of Alzheimer Protein Identifying a cure for Alzheimer’s disease remains a major challenge. Few drugs are … Continue reading
Fisher Scientists Discover New Ways to Rid Cells of Alzheimer Protein
Identifying a cure for Alzheimer’s disease remains a major challenge. Few drugs are currently approved by the Food and Drug Administration to treat Alzheimer’s patients. Unfortunately none of these drugs halt progression of the disease and their impact on cognitive … Continue reading
Key Protein May Lead to Faster Acting Anti-Depression Drugs
By: www.ALZinfo.org There is no single known cause for depression. Depression is believed to result from a combination of genetic, biochemical, environmental and psychological factors. Each year over 17 million American adults experienced a period of clinical depression. In Alzheimer’s … Continue reading
Protein p11 and the Understanding of Depression
By: www.ALZinfo.org Paul Greengard, PhD, director of Fisher Center for Alzheimer’s Disease Research’s team of internationally renowned scientists, has helped discover a protein that seems to be pivotal in lifting depression. The National Institute of Mental Health, a division of … Continue reading
New Drugs for Alzheimer’s Work in Novel Ways
By: www.ALZinfo.org A new class of drugs called gamma-secretase modulators works to reduce the buildup of toxic proteins in the brains of people with Alzheimer’s disease, giving doctors hope that these medications may offer effective new treatments for the devastating … Continue reading
Is an Effective Alzheimer’s Treatment at Hand?: An Expert Speaks
By: www.ALZinfo.org About $1 billion is spent each year on medicines like Aricept, Razadyne, Exelon, and Namenda. These drugs are used primarily to ease symptoms of cognitive loss. In general, improvements are modest. Current medications for Alzheimer’s may slow mental … Continue reading
Plain Talk About Alzheimer’s Research
By Kent L. Karosen President and CEO, Fisher Center Foundation At the Fisher Center for Alzheimer’s Research Foundation, we are funding innovative Alzheimer’s research that is beginning to make serious headway. I wanted to talk to you not as a … Continue reading
